<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-110855</identifier>
<setSpec>0210-573X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Uterine rupture in a patient with intrauterine demise and systemic lupus erythematus</dc:title>
<dc:description xml:lang="en">Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown etiology that can affect any device or system in the body, causing a wide variety of symptoms. This disease is more frequent in women of reproductive age. We report the case of a 32-year-old secundigesta diagnosed with SLE and a mutation in the gene encoding coagulation factor XII, who received treatment with low-dose prednisone and low-molecular weight heparin. The pregnancy was uneventful until week 32 and 5 days, when the patient noted the absence of fetal movements and fetal death was detected. The woman was admitted to hospital for labor induction with two 50mg doses of misoprostol at a 4-hour interval. The mother received epidural analgesia and finally a 1630g boy with no anomalies was extracted through the use of an obstetric vacuum. After the birth, profuse continuous bleeding occurred and a large uterine rupture requiring laparotomic closure was detected (AU)</dc:description>
<dc:creator>Pérez-Herrezuelo, I</dc:creator>
<dc:creator>Valverde Pareja, M</dc:creator>
<dc:creator>Aibar Villan, L</dc:creator>
<dc:creator>González-Pérez, I</dc:creator>
<dc:creator>Puertas Prieto, A</dc:creator>
<dc:creator>Montoya Ventoso, F</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El Lupus Eritematoso Sistémico (LES) es una enfermedad autoinmune de causa desconocida que puede afectar a cualquier aparato o sistema del organismo ocasionando gran variedad de síntomas. Esta enfermedad es más frecuente en las mujeres en edad reproductiva. Secundigesta de 32 años diagnosticada de LES y mutación del gen del factor xii de la coagulación que recibe tratamiento con prednisona a baja dosis y heparina de bajo peso molecular. La gestación cursa sin hallazgos de interés hasta la semana 32 y 5 días, cuando la gestante nota ausencia de movimientos fetales y se evidencia óbito fetal. Se ingresa a la paciente y se inicia inducción del parto con misoprostol en dos dosis de 50 mcg separadas 4 horas; tras las que se inicia el parto. Se instaura analgesia epidural y finalmente se extrae mediante ventosa obstétrica un feto varón de 1.630 g sin anomalías aparentes. Tras el alumbramiento se produce sangrado profuso que no cesa y se evidencia rotura uterina de gran magnitud que precisa cierre laparotómico (AU)</dc:description>
<dc:source>Clín. investig. ginecol. obstet. (Ed. impr.);40(2): 85-88, mar.-abr. 2013. ilus</dc:source>
<dc:identifier>ibc-110855</dc:identifier>
<dc:title xml:lang="es">Rotura uterina en paciente con feto muerto anteparto y lupus eritematoso sistémico</dc:title>
<dc:subject>^d14998</dc:subject>
<dc:subject>^d5424</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d8356^s22012</dc:subject>
<dc:subject>^d7991^s22074</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d29962^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201304</dc:date>
</metadata>
</record>
</ibecs-document>
